Firm
With the US privacy landscape more fragmented and active than ever and federal legislation stalled, lawyers at Sheppard Mullin explain how states are taking bold steps to define their own regimes
A vote to be held in 2026 could create Hogan Lovells Cadwalader, a $3.6bn giant with 3,100 lawyers across the Americas, EMEA and Asia Pacific
Varuni Paranavitane of Finnegan and IP counsel Lisa Ribes compare and contrast two recent AI copyright decisions from Germany and the UK
The new court has drastically changed the German legal market, and the Munich-based firm, with two recent partner hires, is among those responding
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by Tahota Law FirmCharles Feng and Lian Xue of Tahota Law Firm analyse judicial interpretations of China’s Trademark Law and explain why the date of infringement should be the starting point for the ‘preceding three years’ non-use period -
Sponsored by Remfry & SagarBisman Kaur of Remfry & Sagar says recent reports indicate the development of India’s intellectual property culture is continuing apace through progress in areas such as R&D, enforcement, and patent and trademark filings
-
Sponsored by Tilleke & GibbinsWith agriculture a vitally important sector of Cambodia’s economy, Sokmean Chea and Vongkhim Lay of Tilleke & Gibbins provide a guide to the registration of new plant varieties in light of significant developments
-
Sponsored by Tilleke & GibbinsLinh Duy Mai and Giang Hoang Bach of T&G Law Firm LLC (TGVN), the local associate firm of Tilleke & Gibbins, explain why Decree 147 is to be welcomed, although a key issue is unresolved
-
Sponsored by Gün and PartnersUğur Aktekin and Begüm Soydan Sayılkan of Gün + Partners highlight several decisions concerning the Turkish Patent and Trademark Office’s well-known trademark registry and say clarification of its standing is eagerly awaited
-
Sponsored by Maiwald Intellectual PropertyChristian Meyer and Gisela Grabow of Maiwald consider proposals under the European Commission’s Action Plan for Intellectual Property that aim to simplify extended protection for medicinal products through a unitary supplementary protection certificate
